MMIT and MDLinx, a Part of M3 Group, Announce Integration to Deliver Market Access Information Directly to Healthcare Providers Business Wire YARDLEY, Pa. & WASHINGTON -- September 24, 2013 MMIT (www.mmitnow.com) provides trusted formulary data and software solutions to payers, pharmaceutical manufacturers and physicians to help them make informed managed care decisions. Every day MDLinx (www.mdlinx.com) educates and updates nearly half a million healthcare professionals with trusted clinical and medical news content. Together, the combination delivers MMIT’s high integrity information directly to hundreds of thousands of physicians via MDLinx – the #1 ranked specialty website. “Pharmaceutical companies will now have a way to leverage their contracting wins and advantaged formulary status through a doctor trusted network,” said Jeff Steinberg, CEO of MMIT. “Our partnership with MDLinx is a valuable extension of MMIT’s existing pull through platform, one which will provide clients geographically targeted access to the specialists that they want to reach. Most importantly, the tight bundling of online promotional messaging, rebating, and field sales force reinforcement will enhance the ROI of our client’s largest marketing investments.” “We are excited to join with MMIT in the launch of an innovative product that builds upon the broad reach of MDLinx. MMIT’s pharmacist validated market access data nicely complement our historic commitment of providing valuable, informative, practical content to healthcare professionals,” comments Aki Tomaru, CEO of M3 USA. With the proliferation of specialty drugs, reaching specialists with accurate, easily understood information has never been more critical. Pharmaceutical brands can now quickly communicate market access position to targeted groups of physicians and scale this messaging down to a local level. Formally launching at NASP’s Specialty Pharmacy Strategic Business Exchange in October, this joint product is immediately available to a select group of brand teams. For more information, please contact Dan O’Brien at email@example.com or 267.753.6800. About M3 USA The M3 Group operates in the US, Asia, and Europe with over 1.2 million physician members globally via its physician websites such as www.m3.com, www.mdlinx.com, www.doctors.net.uk, and www.medigate.net. MDLinx is an award-winning, practical medical information tool used by busy physicians and healthcare professionals to stay up to date with the latest research in the medical field. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul. About MMIT MMIT provides complete and accurate market access information to the rapidly changing healthcare market. Payers, pharmaceutical manufacturers, healthcare providers and pharmacies use MMIT’s information in important business and decision-making processes to gain the key insights needed to navigate the market’s reforms. Our solutions are used from P&T through to point of care – ensuring consistent, informed managed care decisions across the healthcare spectrum. MMIT is located in Yardley, PA. Contact: MMIT Dan O’Brien, 267-753-6800 firstname.lastname@example.org or M3 USA Richard Britton, 202-293-2288 x9.221 RBritton@usa.m3.com
MMIT and MDLinx, a Part of M3 Group, Announce Integration to Deliver Market Access Information Directly to Healthcare Providers
Press spacebar to pause and continue. Press esc to stop.